EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension

Mitsuaki Kawashima iD, Naohiro Ijiri iD, Chihiro Konoeda iD, Gouji Toyokawa iD, Keita Nakao iD, Yue Cong iD, Haruaki Hino iD, Hideo Kurosawa, Koichi Kashiwa iD, Michiko Ushio iD, Gaku Kawamura, Masahiko Ando iD und 3 weitere

European Journal of Cardio-Thoracic Surgery · 02.08.2025 · 67 (8)

DOI: 10.1093/ejcts/ezaf256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 04.08.2025. Verfasst von Mitsuaki Kawashima und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung Transplantation, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Lung transplantation (LTx) for patients with pulmonary arterial hypertension (PAH) is associated with high postoperative morbidity and mortality. Extracorporeal membrane oxygenation (ECMO) supports patients’ haemodynamics during and after LTx. However, the optimal ECMO strategy, especially for patients with PAH, is debated. Here, we report our unique strategy for patients with PAH, using postoperative central veno-arterial (VA)-ECMO combined with delayed chest closure.

Methods

This was a retrospective single-centre study of consecutive bilateral lung transplantations for adult patients with PAH performed between 2021 and 2024. Patients’ characteristics, perioperative ECMO strategy, and postoperative outcomes were reviewed.

Results

During the study period, 20 PAH patients (idiopathic or hereditary PAH [n = 17], PAH secondary to collagen disease [n = 1], pulmonary veno-occlusive disease [n = 1], and Eisenmenger syndrome [n = 1]) underwent cadaveric LTx. Intraoperative support comprised either central VA-ECMO (n = 17) or cardiopulmonary bypass (n = 3). In 17 patients, central VA-ECMO was maintained postoperatively with temporary skin closure. The reason for postoperative central VA-ECMO was anticipated post-LTx heart failure due to PAH and suboptimal cardiac function. The median duration of ECMO support was 4 days (interquartile range: 2-4). There were 9 (45.0%) haemothorax evacuations while patients were on postoperative central VA-ECMO. No patients experienced haemodynamic collapse after LTx. All patients survived during the observation period, resulting in a 100% survival rate at both 90 days and 1 year (95% confidence interval: 83.2%-100%).

Conclusions

Extended postoperative central VA-ECMO and delayed chest closure were feasible for patients with PAH who underwent LTx. Meticulous haemostasis is mandatory, given the high chance of haemothorax evacuation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationLung TransplantationPulmonary Arterial HypertensionHumansRetrospective StudiesFemaleMaleMiddle AgedAdultTreatment Outcome

Stichwörter der Autor:innen

lung transplantationpulmonary arterial hypertensionveno-arterial extracorporeal membrane oxygenation

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Organ Transplantation Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Department of Clinical Engineering, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
  • Department of Cardiovascular Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.

ORCID-Profile: Mitsuaki Kawashima, Naohiro Ijiri, Chihiro Konoeda, Gouji Toyokawa, Keita Nakao, Yue Cong, Haruaki Hino, Koichi Kashiwa, Michiko Ushio, Masahiko Ando, Shogo Shimada, Minoru Ono, Masaaki Sato

Zitieren

APA

Kawashima, M., Ijiri, N., Konoeda, C., Toyokawa, G., Nakao, K., Cong, Y., Hino, H., Kurosawa, H., Kashiwa, K., Ushio, M., Kawamura, G., Ando, M., Shimada, S., Ono, M., & Sato, M. (2025). Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension. European Journal of Cardio-Thoracic Surgery, 67(8). https://doi.org/10.1093/ejcts/ezaf256

Vancouver

Kawashima M, Ijiri N, Konoeda C, Toyokawa G, Nakao K, Cong Y, et al. Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension. European Journal of Cardio-Thoracic Surgery. 2025;67(8). doi:10.1093/ejcts/ezaf256

BibTeX
@article{Kawashima2025,
  author = {Kawashima, Mitsuaki and Ijiri, Naohiro and Konoeda, Chihiro and Toyokawa, Gouji and Nakao, Keita and Cong, Yue and Hino, Haruaki and Kurosawa, Hideo and Kashiwa, Koichi and Ushio, Michiko and Kawamura, Gaku and Ando, Masahiko and Shimada, Shogo and Ono, Minoru and Sato, Masaaki},
  title = {Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {8},
  doi = {10.1093/ejcts/ezaf256}
}
Kostenlos starten →